Monthly Archives: May 2021
Evaluating the 2020 UK Surveillance Colonoscopy Guidelines on CRC Incidence After Polypectomy
Gut Microbiome Composition is Associated with COVID-19 Disease Severity
Selecting the Ideal Candidate for Anti-TNF Discontinuation in Crohn’s Disease, Dream or Reality?
Pierre N, Baiwir D, Huynh-Thu VA, et al. Discovery of Biomarker Candidates Associated With the Risk of Short-Term and Mid/Long-Term Relapse After Infliximab Withdrawal in Crohn’s Patients: A Proteomics-Based Study [published online ahead of print Octob… Continue reading
Performance of Next Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer with Deficient DNA Mismatch Repair
Next generation sequencing (NGS) was recently approved by the FDA to detect microsatellite instability (MSI) arising from defective mismatch repair (dMMR) in patients with metastatic colorectal cancer (mCRC) prior to treatment with immune checkpoint in… Continue reading
Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
Hopes and hypes for artificial intelligence in colorectal cancer screening
COMMENTARY: New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders
Development of AGA’s policy agenda during the COVID-19 pandemic
The optimal age to stop endoscopic surveillance of Barrett’s esophagus patients based on sex and comorbidity: a comparative cost-effectiveness analysis
Current guidelines recommend surveillance for non-dysplastic Barrett’s esophagus (NDBE) patients but do not include a recommended age for discontinuing surveillance. This study aimed to determine the optimal age for last surveillance of NDBE patients s… Continue reading